AzTrials
AzTrials

OsteoporosisNCT02339051

The Effect of Mechanical Loading on Bone Material Strength and Microarchitecture in Postmenopausal Women

A study testing Jumping on one leg in people with Osteoporosis and Postmenopause, run by Mattias Lorentzon.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Osteoporosis is a large public health disease, characterized by low bone mass and micro architectural deterioration of bone tissue, resulting in enhanced bone fragility and consequent increase in fracture risk. Read more about this study

Who is it for?
Ages 50 to 60 years, women onlyHealthy volunteers can take part
Conditions the study is for
Osteoporosis, Postmenopause
What is being tested?
Jumping on one leg
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
No sites listed yet
Study dates
Jan 2015to Jul 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 60 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • aged between 50 and 60 years,
  • no history of osteoporosis,
  • not undertaken resistance training and/or weight-bearing impact exercise more than once a week in the past three months,
  • be able and willing to perform the intervention program (one leg jumping), and
  • be reachable via telephone once weekly throughout the study

Who cannot join

  • current smoking,
  • current or prior (past 6 months) use of hormone replacement therapy,
  • having sustained a low trauma fragility fracture in the past 6 months,
  • any medical condition (e.g. type 1 diabetes,
  • chronic kidney failure or liver disease, cancer) or
  • use of medication known to influence bone metabolism or fracture risk (e.g. glucocorticoids, thiazide diuretics, anticonvulsants, bisphosphonates), or
  • initiating calcium or vitamin D supplementation in the preceding 6 months

About this study

Osteoporosis is a large public health disease, characterized by low bone mass and micro architectural deterioration of bone tissue, resulting in enhanced bone fragility and consequent increase in fracture risk. Osteoporosis is present when bone mineral density (BMD) or content (BMC), measured by dual-energy X-ray absorptiometry (DXA), is more than 2.5 SDs below the mean value of the young adult. BMD measured by DXA is a surrogate measure of bone strength and is the primary determinant of fracture risk in both men and women. However, the majority of fragility fractures occur in women and in individuals who do not have osteoporosis according to these standards, indicating that BMD is just one among several indicators of bone health and that assessment of fracture risk should also rely on other bone properties. Newer imaging methods, such as quantitative computerized tomography (QCT), can complement information from DXA-measurements due to its ability to assess volumetric BMD and bone geometry and to differentiate between cortical and trabecular bone compartments. Bones are composite materials made predominantly of living cells, extracellular matrix, water and lipids. This composite nature of the bone material enables it to absorb stresses by elastic deformation and to endure high loads before fracturing. A new in vivo measurements of bone material strength can be used to evaluate bone mechanical properties and thereby the fracture risk. It is well established that the skeleton benefits, in terms of increased density, from regular physical activity. However, changes in BMD are still the main surrogate for assessing improvements in exercise-induced bone health despite the experimental findings as well as findings in humans showing that improvements in mechanical bone properties are independent of changes in BMD. These improvements in mechanical bone properties may be due to changes in bone shape or matrix composition. It could then be argued that a decrease in BMD is only one of the possible manifestations of osteoporosis and that bone strength or fragility is multifactorial. The objective for this study is to investigate the role of mechanical loading on bone material strength and bone microarchitecture in middle-aged women. The overall hypothesis is that mechanical loading is a regulator of bone material strength and microarchitecture in middle-aged women. This is an intervention study where the participants will act as their own controls. The investigators intend to include 40 postmenopausal and healthy women 50-60 years of age in the study. Advertisements in local papers and at the hospital will be used to come into contact with suitable study subjects. The women will be asked to perform an intervention program, including jumping on one leg every day during a 3-month period according to a protocol with a gradually increasing load/number of jumps. The women have to choose one of their legs as intervention-leg and stick to the chosen leg throughout the study. The leg without intervention will be used as a control. Both bone material strength (BMS) and bone microarchitecture will be measured before and after intervention in both legs (tibia). The operators measuring BMS (OsteoProbe®) and bone microarchitecture (high resolution pQCT) will be blinded concerning each participant's choice of leg for intervention. In addition, subjects will be asked to register daily physical activity in a structured diary. The primary outcome measure will be changes in bone material strength (BMS) in the lower leg (tibia) with intervention compared to the leg (tibia) without intervention. Participants will attend two clinic visits, at baseline and after 3 months when the intervention period is completed. The secondary outcome measures will be changes in total volumetric density, cortical volumetric density, cortical cross sectional area and trabecular bone volume fraction in the lower leg (tibia) with intervention compared to the leg (tibia) without intervention.

Being tested
Jumping on one leg
Keywords
Basic Science
Medical subject headings
Osteoporosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Jumping on one legBehavioural

Study groups in NCT02339051
Study groupRoleWhat they receive
One leg jumpingExperimentalStudy subjects will jump on one leg on repeated occasions (incremental daily repetitions) for a period of three months. The same leg will be used for jumping throughout the study. The other leg will serve as control.
Receives: Behavioral: Jumping on one leg

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in bone material strength in the tibia (measured using OsteoProbe®)

    Bone material strength measured using OsteoProbe®

    Measured: Three months

Secondary outcomes (4)
  1. Changes in total volumetric density in the tibia (Measured using high-resolution pQCT device (HR-pQCT)

    Measured using high-resolution pQCT device (HR-pQCT) (XtremeCT, Scanco Medical AG, Switzerland)

    Measured: Three months

  2. Changes in cortical volumetric density in the tibia (Measured using high-resolution pQCT device (HR-pQCT)

    Measured using high-resolution pQCT device (HR-pQCT) (XtremeCT, Scanco Medical AG, Switzerland)

    Measured: Three months

  3. Changes in cortical cross sectional area in the tibia (Measured using high-resolution pQCT device (HR-pQCT)

    Measured using high-resolution pQCT device (HR-pQCT) (XtremeCT, Scanco Medical AG, Switzerland)

    Measured: Three months

  4. Changes in trabecular bone volume fraction in the tibia (Measured using high-resolution pQCT device (HR-pQCT)

    Measured using high-resolution pQCT device (HR-pQCT) (XtremeCT, Scanco Medical AG, Switzerland)

    Measured: Three months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jan 2015 (estimated)
  2. Study startJan 2015
  3. Primary completionJul 2015
  4. Study completionJul 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02339051
Sponsor's protocol ID
Dnr 563-14
Status last verified
Jul 2016
First submitted
12 Jan 2015
Last updated
11 Jul 2016
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Jumping on one leg in people with Osteoporosis and Postmenopause, run by Mattias Lorentzon.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in bone material strength in the tibia (measured using OsteoProbe®) (time frame: Three months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jul 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in